|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Receivable from related party | |||||
| Total Current Assets | |||||
| Available-for-sale debt securities held in Trust Account, at fair value (amortized cost $105,286,044 and $101,881,727 as of September 30, 2025 and December 31, 2024, respectively) | |||||
| Forward sale securities asset | |||||
| Other assets | |||||
| Total Assets | |||||
| Liabilities and Shareholders’ Deficit: | |||||
| Current Liabilities: | |||||
| Accrued expenses | |||||
| Note payable – related party | |||||
| Payable to related party | |||||
| Total Liabilities | |||||
| Class A ordinary shares subject to possible redemption, 10,000,000 shares issued and outstanding at redemption value of $10.68 and $10.35 per share as of September 30, 2025 and December 31, 2024, respectively | |||||
| Shareholders’ Deficit: | |||||
| Ordinary shares, Value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Accumulated deficit | |||||
| Accumulated other comprehensive income | |||||
| Total Shareholders’ Deficit | |||||
| Total Liabilities, Commitments and Contingencies and Shareholders’ Deficit |
Loading...
